Date: 2012-05-09
Type of information: Co-promotion agreement
Compound: NextGENe® software
Company: Roche 454 Life Sciences (Switzerland - USA) SoftGenetics (USA)
Therapeutic area: Technology - Services
Type agreement: co-promotion
Action mechanism: NextGENe® software is a free standing biologist-friendly software multi-package that is fully compatibility with 454 Sequencing data for a wide variety of applications, including targeted amplicon resequencing, exome sequencing, transcriptome sequencing, forensic profiling and more. The software package provides additional options for users of 454 Sequencing Systems, in addition to the extensive GS Data Analysis Software suite provided with the platforms.
Disease:
Details: 454 Life Sciences, a Roche Company, and SoftGenetics have entered into a co-promotion agreement designed to provide users of 454 Sequencing Systems the broad range of next-generation sequencing data analysis options provided by SoftGenetics NextGENe® software. SoftGenetics offers 30-day trials and no cost web-based training on its genetic analysis software packages. SoftGenetics specializes in the development of genetic analysis tools for both research and diagnostic applications. Hallmarks of SoftGenetics software tools are advanced technologies, providing exceptional accuracy, and sensitivity in an easy to use Windows® user interface.
Financial terms:
Latest news:
